HIV Infections Clinical Trials in Seattle, Washington

7 studies are recruiting for hiv infections in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

   The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged 18 to 60 years, who previously participated in the HVTN 706 trial.

   Stage

   Phase 1

   Ages

   18 to 60

   Site

   Seattle Vaccine and Prevention CRS, Seattle, Washington

   Locations

   9 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT06665646 on ClinicalTrials.gov

2. Positive Peers Intervention Clinical Trial

   The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are ass…

   Stage

   Not phased

   Ages

   13 to 34

   Site

   UW Madison Clinic at Harborview, Seattle, Washington

   Locations

   7 in total

   Run by

   MetroHealth Medical Center

   See if you can join NCT06388109 on ClinicalTrials.gov

3. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

   This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Seattle, Washington

   Locations

   88 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07650916 on ClinicalTrials.gov

4. Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

   The goal of this clinical study is to compare how effective a long-acting injectable treatment of lenacapavir (LEN), teropavimab (TAB), and zinlirvimab (ZAB) versus (CAB) and rilpivirine (RPV) injections given every 8 weeks in adults with HIV-1 whose virus is well controlled on daily oral treatment…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   TribalMed PLLC, Seattle, Washington

   Locations

   19 in total

   Run by

   Gilead Sciences

   See if you can join NCT07682961 on ClinicalTrials.gov

5. Dasatinib for HIV-1 Reservoir Reduction

   This study will test if the medicine dasatinib can lower the hidden amount of HIV in the body, called the HIV "reservoir." It will also check if dasatinib is safe and easy to take for people living with HIV who have a suppressed viral load while on antiretroviral therapy (ART). Adults 18 years or o…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   1401, University of Washington Positive Research CRS, Seattle, Washington

   Locations

   3 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07342491 on ClinicalTrials.gov

6. A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

   This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   GSK Investigational Site, Seattle, Washington

   Locations

   123 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07202546 on ClinicalTrials.gov

7. Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV

   People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise interventions or exam…

   Stage

   Not phased

   Ages

   50 to 80

   Site

   University of Washington, Seattle, Washington

   Locations

   3 in total

   Run by

   University of Alabama at Birmingham

   See if you can join NCT06013579 on ClinicalTrials.gov